Biofrigas (BIOF) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
28 Aug, 2026Executive summary
Achieved commercial operation at Habo facility, producing high-quality liquefied biogas (LBG) suitable for vehicle fuel, marking a key technical and commercial milestone for local LBG production.
Focused on optimizing Habo, launching phase 2, leveraging reference projects for new business, and strengthening sales efforts.
Secured investment support for a permanent biogas station at Habo, advancing customer projects and market positioning.
Financial highlights
Net sales were KSEK 0 for Q2 2026 (unchanged year-over-year); other operating income was KSEK 967 (up from 118).
Result after financial items for Q2 was KSEK -3,201 (improved from -3,341); for H1 2026, result was KSEK -5,929 (slightly worse than -5,900).
Earnings per share for Q2 was -0.02 SEK (improved from -0.06); for H1, -0.04 SEK (improved from -0.10).
Cash flow for Q2 was KSEK 3,015 (up from 1,859), mainly due to new share issue and loan repayment.
Outlook and guidance
Entering a commercial expansion phase in 2026, with focus on completing Habo phase 2, advancing customer dialogues, and converting technical progress into commercial results.
Market demand for renewable fuels and local LBG production is expected to remain strong.
Latest events from Biofrigas
- First customer unit reached commercial operation; rights issue launched for expansion.BIOF
Q1 2026 - First customer delivery and demo achieved, but revenue dropped to zero and losses increased.BIOF
Q4 2025 - First biogas plant delivered, sales down, equity ratio up, new capital raised.BIOF
Q3 2025 - No sales in Q2, but capital raised and promising tests set stage for scale-up and new leadership.BIOF
Q2 2025 - First customer revenue, capital raise, and EU biogas tax approval mark a pivotal Q3.BIOF
Q3 2024 - Q2 2024 saw Biofrigas post first revenues, a net loss, and strong market momentum.BIOF
Q2 2024 - First customer unit delivered, US patent granted, and new financing secured for expansion.BIOF
Q1 2025 - First revenues, capital raise, and regulatory tailwinds position Biofrigas for future growth.BIOF
Q4 2024